Madrigal Pharmaceuticals
MDGL
#2088
Rank
โ‚ฌ8.02 B
Marketcap
345,51ย โ‚ฌ
Share price
-4.45%
Change (1 day)
-28.23%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): -5,06ย โ‚ฌ

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -5,39ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -9,74ย โ‚ฌ an increase over its 2024 EPS that were of -20,15ย โ‚ฌ.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,06ย โ‚ฌ-48.04%
2025-9,74ย โ‚ฌ-51.65%
2024-20,15ย โ‚ฌ
2022-15,70ย โ‚ฌ17.93%
2021-13,32ย โ‚ฌ11.61%
2020-11,93ย โ‚ฌ140.18%
2019-4,97ย โ‚ฌ146.61%
2018-2,01ย โ‚ฌ-12.99%
2017-2,31ย โ‚ฌ-91.03%
2016-25,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,17ย โ‚ฌ-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,87ย โ‚ฌ-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA